26U vs RHO6: Side-by-Side Comparison
Compare 26U (26U) and Roche Holding AG (RHO6) side by side: valuation, financials, growth and model signals on Bullrun.
| Metric | 26U | RHO6 |
|---|---|---|
| Company | 26U | Roche Holding AG |
| Country / Exchange | Switzerland · F | Switzerland · STU |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - General |
| Market cap | EUR 127.86M | — |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 10.80M | EUR 63.36B |
| Revenue growth YoY | +56.6% | +1.5% |
| Net income | EUR -1.42M | EUR 12.88B |
| Gross margin | 26.3% | 73.7% |
| Diluted EPS | -0.28 | 16.04 |